Bioxcel Therapeutics Inc.

Patent cliffs & loss of exclusivity

Sublingual thin film formulation, oral small molecule

Company

Legal NameBioXcel Therapeutics, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.bioxceltherapeutics.com/contact-us/
Crunchbase URLhttps://www.crunchbase.com/organization/bioxcel-therapeutics
Facebook URLhttps://www.facebook.com/bioxcel-therapeutics-inc-108817271542372
Full Address555 Long Wharf Drive 12th Floor New Haven, CT 06511 United States
LinkedIn URLhttp://www.linkedin.com/company/bioxcel-therapeutics
Pitchbook URLhttps://pitchbook.com/profiles/company/225816-31

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. IGALMIDEXMEDETOMIDINE HYDROCHLORIDESmall mol.Jan 2043
  2. IGALMIDEXMEDETOMIDINE HYDROCHLORIDESmall mol.Jan 2043

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.